Invention Grant
- Patent Title: Raccoon poxvirus expressing rabies glycoproteins
- Patent Title (中): 表达狂犬病糖蛋白的浣熊痘病毒
-
Application No.: US12128296Application Date: 2008-05-28
-
Publication No.: US08795681B2Publication Date: 2014-08-05
- Inventor: Stephen Qitu Wu , Michael A. Gill , Hsien-Jue Chu
- Applicant: Stephen Qitu Wu , Michael A. Gill , Hsien-Jue Chu
- Applicant Address: US MO St. Joseph
- Assignee: Boehringer Ingelheim Vetmedica, Inc.
- Current Assignee: Boehringer Ingelheim Vetmedica, Inc.
- Current Assignee Address: US MO St. Joseph
- Agent Michael P. Morris; Joyce L. Morrison
- Main IPC: A61K39/205
- IPC: A61K39/205 ; A61K39/275 ; A61K39/295 ; A61K39/116 ; C12N7/01 ; C12N15/863

Abstract:
The present invention relates to recombinant raccoon poxvirus vectors that express the rabies virus glycoprotein gene at the hemagglutinin (ha) locus of the poxvirus genome or express the glycoprotein gene of the same or different rabies strains at the thymidine kinase (tk) and the hemagglutinin (ha) loci of the poxvirus genome, and their use as adjuvant-free vaccines. The raccoon poxvirus vector comprises the nucleic acid molecules encoding the glycoprotein of a Challenge Virus Standard rabies strain inserted and expressed at the tk locus of the poxvirus genome and of a Pasteur-Paris rabies strain inserted and expressed at the ha locus of the poxvirus genome. The vaccine may optionally contain a mixture of additional feline and canine antigens for immunization of animals. Also disclosed are methods for inducing an immune response to rabies in a mammal by administering to the mammal an effective immunizing amount of the vaccine of the invention.
Public/Granted literature
- US20090010963A1 Raccoon Poxvirus Expressing Rabies Glycoproteins Public/Granted day:2009-01-08
Information query